proxyvotesnow.com

Home › Asset managers › Pacific Life › 2024-2025 › Against the board

Pacific Life 2024-2025: where it broke with the board

Two kinds of vote are listed: a board-sponsored proposal Pacific Life voted AGAINST or withheld on, and a shareholder proposal it voted FOR, with the board’s recommendation on it where the filings show one. A FOR vote on a proposal the board supported, or took no position on, is listed and labelled, but it is not a vote against the board. One row is one proposal at one meeting; “funds” is how many of the manager’s funds or accounts voted that way.

Everything Only shareholder proposals it backed

4,509 proposals.

Pacific Life, 2024-2025 proxy season. Who put a proposal on the ballot is taken from the filer’s own N-PX answer (Item 1(h)), or, marked “inferred”, from its category and wording where the filing does not say; see the method note on the overview page.
CompanyMeetingProposalCategory On the ballot fromBoard recommendedPacific Life votedFunds
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Completeness and Compliance of Implementation of Legal Proceedings of the Transaction and Validity of the Submitted Legal Documents Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Confidentiality Measures and Confidentiality System Adopted for This Transaction Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Description of the Basis and Fairness and Reasonableness of the Pricing of the Transaction Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Distribution Arrangement of Undistributed Earnings Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Fluctuation of the Company's Stock Price Before the Release of Information on This Transaction Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Impact of Dilution of Current Returns on Major Financial Indicators, the Relevant Measures to be Taken and Commitment from Relevant Parties Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Independence of Appraiser, the Validity of Hypothesis, the Relevance of Valuation Method and Purpose and Approach as Well as the Fairness of Pricing Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Issue Amount Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Issue Amount and Number of Issues Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Issue Manner and Target Subscribers Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Issue Type, Par Value and Listing Location Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Lock-Up Period Arrangement Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Overall Plan Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Performance Commitment and Compensation Arrangement Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Pricing Reference Date and Issue Price Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Purchases and Sales of Assets in the Twelve Months Prior to the Transaction Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Report (Draft) and Summary on Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds and Related Party Transactions Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Report on the Usage of Previously Raised Funds Capital Structure Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Resolution Validity Period Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Signing of Conditional Agreement to the Issuance of Shares and Acquisition by Cash as well as Performance Compensation Agreement Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Target Assets Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Complies With Article 18 and 21 of the Measures for the Continuous Supervision of ChiNext Listed Companies (Trial) and Article 8 of the Shenzhen Stock Exchange Listed Company Major Asset Restructuring Review Rules Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Complies With Article 4 of Guidelines for the Supervision of Listed Companies No. 9 - Regulatory Requirements for Listed Companies to Plan and Implement Major Asset Restructuring Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Complies with Articles 11 and 43 of the Measures for the Administration of Major Asset Restructuring of Listed Companies Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Complies with the Relevant Provisions of the Administrative Measures for the Registration of Securities Issuance of Listed Companies Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Constitute as Major Asset Restructuring and Does Not Constitute as Restructuring and Listing Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Parties Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Transaction Price and Payment Method Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve Use of Proceeds Capital Structure Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve the Company's Plan for Issuance of Shares and Acquisition by Cash as Well as Raising Supporting Funds Complies with Relevant Laws and Regulations Extraordinary Transactions Board AGAINST 1
CSPC Innovation Pharmaceutical Co., Ltd. 2024-10-31 Approve the Relevant Entity of Transaction Does Not Exist in Article 12 of Listed Company Supervision Guidelines No. 7 and Article 30 of the Guidelines for Self-regulatory Supervision No. 8 (Revised in 2023) Extraordinary Transactions Board AGAINST 1
CSX Corporation 2025-05-07 Advisory (non-binding) resolution to approve compensation for the Company's named executive officers. Say-on-Pay Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: David M. Moffett Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: J. Steven Whisler Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: James L. Wainscott Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: Joseph R. Hinrichs Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: Linda H. Riefler Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: Steven T. Halverson Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: Suzanne M. Vautrinot Director Elections Board AGAINST 1
CSX Corporation 2025-05-07 Election of Directors: Thomas P. Bostick Director Elections Board AGAINST 1
CVR Energy, Inc. 2025-06-05 To approve the Third Amended & Restated CVR Energy, Inc. 2007 Long-Term Incentive Plan. Compensation Board AGAINST 1
CVR Energy, Inc. 2025-06-05 To approve, on an advisory basis, our named executive officer compensation. Say-on-Pay Board AGAINST 1
CVS Health Corporation 2025-05-15 Say on Pay, a Proposal to Approve, on an Advisory Basis, the Company's Executive Compensation. Say-on-Pay Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Brad D. Brian Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Deborah J. Kissire Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Julia M. Laulis Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Katharine B. Weymouth Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Mary E. Meduski Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: P. Robert Bartolo Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Sherrese M. Smith Director Elections Board AGAINST 1
Cable One, Inc. 2025-05-15 Election of Directors: Wallace R. Weitz Director Elections Board AGAINST 1
Cabot Corporation 2025-03-13 To approve the Cabot Corporation 2025 Long-Term Incentive Plan. Compensation Board AGAINST 1
Caitong Securities Co., Ltd. 2025-06-19 Approve General Authorization for Domestic and Overseas Debt Financing Instruments Capital Structure Board AGAINST 1
Caitong Securities Co., Ltd. 2025-06-19 Approve Securities Investment Extraordinary Transactions Board AGAINST 1
Caixa Seguridade Participacoes SA 2025-04-25 Elect Francisco Egidio Pelucio Martins as Director Director Elections Board AGAINST 1
Caixa Seguridade Participacoes SA 2025-04-25 Elect Humberto Jose Teofilo Magalhaes as Director Director Elections Board AGAINST 1
Caixa Seguridade Participacoes SA 2025-04-25 Elect Ilana Trombka as Director Director Elections Board AGAINST 1
Caixa Seguridade Participacoes SA 2025-04-25 Elect Ines da Silva Magalhaes as Director Director Elections Board AGAINST 1
Caixa Seguridade Participacoes SA 2025-04-25 Elect Karoline Busatto as Director Director Elections Board AGAINST 1
Caixa Seguridade Participacoes SA 2025-04-25 In Case Cumulative Voting Is Adopted, Do You Wish to Equally Distribute Your Votes Amongst the Nominees below? Director Elections Board ABSTAIN 1
Caixa Seguridade Participacoes SA 2025-04-25 Percentage of Votes to Be Assigned - Elect Francisco Egidio Pelucio Martins as Director Director Elections Board ABSTAIN 1
Caixa Seguridade Participacoes SA 2025-04-25 Percentage of Votes to Be Assigned - Elect Humberto Jose Teofilo Magalhaes as Director Director Elections Board ABSTAIN 1
Caixa Seguridade Participacoes SA 2025-04-25 Percentage of Votes to Be Assigned - Elect Ilana Trombka as Director Director Elections Board ABSTAIN 1
Caixa Seguridade Participacoes SA 2025-04-25 Percentage of Votes to Be Assigned - Elect Ines da Silva Magalhaes as Director Director Elections Board ABSTAIN 1
Caixa Seguridade Participacoes SA 2025-04-25 Percentage of Votes to Be Assigned - Elect Karoline Busatto as Director Director Elections Board ABSTAIN 1
Caixa Seguridade Participacoes SA 2025-04-25 Percentage of Votes to Be Assigned - Elect Waldemir Bargieri as Independent Director Director Elections Board ABSTAIN 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: Adolphus B. Baker Director Elections Board WITHHOLD 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: Camille S. Young Director Elections Board WITHHOLD 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: James E. Poole Director Elections Board WITHHOLD 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: Letitia C. Hughes Director Elections Board WITHHOLD 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: Max P. Bowman Director Elections Board WITHHOLD 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: Sherman L. Miller Director Elections Board WITHHOLD 1
Cal-Maine Foods, Inc. 2024-10-04 Election of Directors: Steve W. Sanders Director Elections Board WITHHOLD 1
Calavo Growers, Inc. 2025-04-23 APPROVAL OF THE AMENDMENT AND RESTATEMENT OF THE CALAVO GROWERS, INC. 2020 EQUITY INCENTIVE PLAN Compensation Board AGAINST 1
Caleres, Inc. 2025-05-22 Approval, by non-binding advisory vote, of the Company's executive compensation. Say-on-Pay Board AGAINST 1
Camden National Corporation 2025-05-20 To approve an amendment to the Company's 2022 Equity and Incentive Plan to increase the number of shares issuable under the plan and to extend the term of the plan to 2035. Compensation Board AGAINST 1
Canara Bank 2024-11-27 Elect Deepak Arora as Director Director Elections Board AGAINST 1
Canara Bank 2024-11-27 Elect Hemant Buch Director Elections Board ABSTAIN 1
Canara Bank 2024-11-27 Elect Hemant Buch as Director Director Elections Board AGAINST 1
Capgemini SE 2025-05-07 Reelect Kurt Sievers as Director Director Elections Board AGAINST 1
Capital Bancorp, Inc. 2025-05-15 Proposal to approve on a non-binding, advisory basis, the compensation of the Company's named executive officers, as described in the proxy statement. Say-on-Pay Board AGAINST 1
Cars.com Inc. 2025-06-04 Approval of the Amended and Restated Cars.com Inc. Omnibus Incentive Compensation Plan. Compensation Board AGAINST 1
Carter's, Inc. 2025-05-14 Advisory approval of compensation of our named executive officers. Say-on-Pay Board AGAINST 1
Catalyst Pharmaceuticals, Inc. 2025-05-20 To approve an amendment to our 2018 Stock Incentive Plan to increase the shares available for issuance by 5 million shares. Compensation Board AGAINST 1
Catalyst Pharmaceuticals, Inc. 2025-05-20 To approve, on an advisory basis, the 2024 compensation of our named executive officers. Say-on-Pay Board AGAINST 1
Catcher Technology Co., Ltd. 2025-05-27 Elect CHAN Wen Hsiung Director Elections Board AGAINST 1
Catcher Technology Co., Ltd. 2025-05-27 Elect Foreky WONG Director Elections Board AGAINST 1
Catcher Technology Co., Ltd. 2025-05-27 Elect Irwin LIM Kee Way Director Elections Board AGAINST 1
Catcher Technology Co., Ltd. 2025-05-27 Elect LEI Mon Huan Director Elections Board AGAINST 1
Cathay General Bancorp 2025-05-12 Approval, on a non-binding advisory basis, of the compensation paid to Cathay General Bancorp's named executive officers as disclosed in the proxy statement. Say-on-Pay Board AGAINST 1
Cathay General Bancorp 2025-05-12 Approval, on the Cathay General Bancorp 2005 Incentive Plan, As Amended and Restated. Compensation Board AGAINST 1
CelcomDigi Bhd. 2025-05-22 Elect Irfan UL Wahab Khan as Director Director Elections Board AGAINST 1
CelcomDigi Bhd. 2025-05-22 Elect Jon Omund Revhaug as Director Director Elections Board AGAINST 1
CelcomDigi Bhd. 2025-05-22 Elect Nik Rizal Kamil Bin Nik Ibrahim Kamil as Director Director Elections Board AGAINST 1
CelcomDigi Bhd. 2025-05-22 Elect Rita Skjaervik as Director Director Elections Board AGAINST 1
CelcomDigi Bhd. 2025-05-22 Elect Vivek Sood as Director Director Elections Board AGAINST 1
Celltrion, Inc. 2025-03-25 Elect Seo Jeong-jin as Inside Director Director Elections Board AGAINST 1
Cenovus Energy Inc. 2025-05-08 Elect Director Frank J. Sixt Director Elections Board AGAINST 1
Centrais Eletricas Brasileiras SA 2025-04-29 Elect Guido Mantega as Fiscal Council Member and Regis Anderson Dudena as Alternate (Appointed by Uniao Federal) Compensation Board ABSTAIN 1
Centrais Eletricas Brasileiras SA 2025-04-29 Elect Mauricio Tolmasquim as Director (Appointed by Uniao Federal - Candidate Could Be Withdrawn) Director Elections Board ABSTAIN 1

← Previous Page 18 of 46 Next →

← Back to Pacific Life 2024-2025 overview

Built 2026-10-12 from SEC Form N-PX filings.